Table 1. Characteristics of Study Population (n = 225).
| Variable | Value |
|---|---|
| Age, mean ± SD | 73.1 (±5.8) |
| Sex (Female), n (%) | 128 (56.9) |
| Living alone, n (%) | 51 (22.7) |
| Body Mass Index, mean ± SD | 29.93 (±5.2) |
| Body Mass Index, n (%): | |
| Normal weight | 26 (11.2) |
| Overweight | 100 (44.8) |
| Obesity | 59 (26.5) |
| Morbid obesity | 38 (17) |
| Charlson Comorbidity Index, mean ± SD | 1.73 (±1.8) |
| Charlson Comorbidity Index, n (%): | |
| 0 | 66 (29.3) |
| 1–2 | 107 (47.6) |
| 3–4 | 30 (13.3) |
| 5 or more | 22 (9.8) |
| Most prevalent chronic diseases, n (%): | |
| Hypertension | 172 (76.8) |
| Osteoarticular disease | 163 (72.4) |
| Dyslipidemia | 118 (52.4) |
| Insomnia | 105 (46.7) |
| Peripheral vascular disease | 97 (43.1) |
| Gastrointestinal disease | 93 (41.3) |
| Diabetes mellitus | 82 (36.4) |
| Psychopathology | 77 (34.2) |
| Heart disease | 72 (32.1) |
| SPMSQ (0–2 errors), n (%) | 207 (92.8) |
| ADL (Katz: A-B), n (%) | 209 (94.5) |
| IADL (Lawton: ≥6), n (%) | 176 (78.5) |
| GDS-15, n (%): | |
| 0–5 | 169 (75.8) |
| 6–9 | 45 (20.2) |
| 10 or more | 9 (4) |
| Number of medications per patient, mean ± SD | 7.1 (±3.8) |
| Medications (receipt of >1), n (%): | |
| Cardiovascular (C Group) | 187 (83.1) |
| Digestive and Metabolism (A Group) | 170 (75.5) |
| Nervous System (N Group) | 159 (70.6) |
| Blood & blood forming organs (B Group) | 106 (47.1) |
SPMSQ: Short Portable Mental Status Questionnaire; ADL: Activity of Daily Living; IADL: Instrumental Activities of Daily Living; GDS-15: Geriatric Depression Scale (<5: no depression; >5: suggestive of depression; >10: almost always depression).